Literature DB >> 19472851

Sensitivity and specificity of nerve palpation, monofilament testing and voluntary muscle testing in detecting peripheral nerve abnormality, using nerve conduction studies as gold standard; a study in 357 patients.

Fatema Abbas Khambati1, Vanaja Prabhakar Shetty, Sunil Dattatraya Ghate, Gospi Dolly Capadia.   

Abstract

OBJECTIVE: To determine sensitivity and specificity of clinical tools viz. nerve palpation (NP), monofilament (MF), and voluntary muscle testing (VMT), for assessing peripheral nerve function impairment (NFI) in leprosy, using nerve conduction studies (NCS) as gold standard. STUDY POPULATION AND METHODS: 357 untreated multibacillary (MB) leprosy patients were assessed using above tests. The nerves assessed were left and right ulnar, median, radial cutaneous, sural, common peroneal and posterior tibial. The concordance between the clinical and NCS tests was done for each nerve. The sensitivity and specificity of clinical tests for detecting nerve impairment was determined, using NCS as gold standard. Analysis was performed using SPSS version 10.0.
RESULTS: The sensitivity of NP ranged between 71% to 88% for all nerves, except the median (43%) and sural (59%) nerves. Specificity was > 60% for all, but low for ulnar (34%) and common peroneal (40%) nerves. The specificity of MF testing was > 80% and of VMT assessment was >90% for all nerves. The sensitivity of MF testing ranged between 35-44%, while of VMT assessment was very low i.e. 4-5%, the maximum was for the ulnar nerve (25%). Detection sensitivity of MF testing and VMT assessment improved two fold when combined with NP and was closely comparable to NCS test findings.
CONCLUSIONS: Both MF testing and VMT assessment showed good specificity, but moderate to low sensitivity. NP was less specific but more sensitive than MF testing and VMT assessment. Combining NP with MF testing and VMT assessment gives a two fold improvement in the sensitivity for assessing nerve damage and could therefore serve as the most useful clinical tools for diagnosis of leprosy and detecting nerve damage at field level.

Entities:  

Mesh:

Year:  2009        PMID: 19472851

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  5 in total

1.  Response to: "Some patients with chronic pain need low-dose opioid therapy for survival and quality of life".

Authors:  Helene Bertrand
Journal:  CMAJ       Date:  2018-05-22       Impact factor: 8.262

2.  Clinical and Neurophysiological Features of Leprosy Patients with Neuropathic Pain.

Authors:  Louise Mara Giesel; Izabela Jardim Rodrigues Pitta; Raquel Custódio da Silveira; Lígia Rocha Andrade; Robson Teixeira Vital; José Augusto da Costa Nery; Mariana de Andrea Vilas Boas Hacker; Euzenir Nunes Sarno; Marcia Maria Jardim Rodrigues
Journal:  Am J Trop Med Hyg       Date:  2018-03-29       Impact factor: 2.345

3.  Progression of leprosy neuropathy: a case series study.

Authors:  Robson T Vital; Ximena Illarramendi; Osvaldo Nascimento; Mariana A Hacker; Euzenir N Sarno; Marcia R Jardim
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

Review 4.  Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management.

Authors:  Kou-Huang Chen; Cheng-Yao Lin; Shih-Bin Su; Kow-Tong Chen
Journal:  J Trop Med       Date:  2022-07-04

5.  Reflections on osteopathic fascia treatment in the peripheral nervous system.

Authors:  Bruno Bordoni; Giovanni Bordoni
Journal:  J Pain Res       Date:  2015-10-30       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.